Abstract
Pyoderma gangrenosum could be, in some cases, the most visible manifestation of a systemic disease. Once histological confirmation of pyoderma gangrenosum by biopsy is made and other causes of skin lesions had been excluded, it is important to conduct a comprehensive diagnostic workup to determine if the lesion is associated with a systemic disease. In the context of this patient, it was determined that these skin lesions were associated with inflammatory bowel disease that had not been previously documented. The treatment of these two pathologies goes hand in hand, so is relevant to determine the characteristics of each patient in order to achieve appropriate therapeutic interventions.
Keywords
References
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet [Internet]. 2017 (citado 15 noviembre 2023);389(10080):1756-1770. DOI: 10.1016/S0140-6736(16)32126-2
Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review. JAMA [Internet]. 12 septiembre 2023 (citado 15 noviembre 2023);330(10):951-965. DOI: 10.1001/jama.2023.15389
Weizman AV, Huang B, Targan S, et al. Pyoderma gangrenosum among patients with inflammatory bowel disease: a descriptive cohort study. J Cutan Med Surg. [Internet]. 2015 (citado 15 noviembre 2023);19(2):125-131. DOI: 10.2310/7750.2014.14053
Plumptre I, Knabel D, Tomecki K. Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflamm Bowel Dis. [Internet]. 2018 (citado 15 noviembre 2023);24(12):2510-2517. DOI: 10.1093/ibd/izy174
Figueras Nart I, Martín-Sala S, Álvarez-Abella A, Jucglà Serra A. Pioderma gangrenoso. Piel [Internet]. 2012 (citado 15 noviembre 2023);27(3):132–144. DOI: 10.1016/j.piel.2011.10.012
Ford AC, Moayyedi P, Hanauer SB. Ulcerative colitis. BMJ [Internet]. 2013 (citado 15 noviembre 2023);346:f432. DOI:10.1136/bmj.f432
Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet [Internet]. 2012 (citado 15 noviembre 2023);380(9853):1606-19. DOI: 10.1016/S0140-6736(12)60150
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol [Internet]. Marzo 2019 (citado 15 noviembre 2023);114(3):384-413. DOI: 10.14309/ajg.0000000000000152
Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms. Dtsch Arztebl Int. [Internet]. 17 agosto 2020 (citado 15 noviembre 2023);117(33-34):564-574. DOI: 10.3238/arztebl.2020.0564
Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. J Clin Med. [Internet]. 20 abril 2022 (citado 15 noviembre 2023);11(9):2302. DOI: 10.3390/jcm11092302
Wollina U. Pyoderma gangrenosum--a review. Orphanet J Rare Dis. [Internet]. 2007 (citado 15 noviembre 2023);2:19. DOI: 10.1186/1750-1172-2-19
Ahn C, Negus D, Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. [Internet]. 2018 (citado 15 noviembre 2023);14(3):225-233. DOI: 10.1080/1744666X.2018.1438269
Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. [Internet]. 2012 (citado 15 noviembre 2023);13(3):191-211. DOI: 10.2165/11595240-000000000-00000
George C, Deroide F, Rustin M. Pyoderma gangrenosum – a guide to diagnosis and management. Clin Med (Lond) [Internet]. 2019 (citado 15 noviembre 2023); 19(3): 224–228. DOI: 10.7861/clinmedicine.19-3-224
Flora A, Kozera E, Frew JW. Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease. Exp Dermatol. [Internet]. Abril 2022 (citado 15 noviembre 2023);31(4):498-515. DOI: 10.1111/exd.14534
Rodríguez-Zúñiga MJM, Heath MS, Gontijo JRV, Ortega-Loayza AG. Pyoderma gangrenosum: a review with special emphasis on Latin America literature. An Bras Dermatol. [Internet]. Nov-Dic 2019 (citado 15 noviembre 2023);94(6):729-743. DOI: 10.1016/j.abd.2019.06.001
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. [Internet]. 01 abril 2018 (citado 15 noviembre 2023);154(4):461-466. DOI: 10.1001/jamadermatol.2017.5980
Alavi A, French L, Davis M, Brassard A, Kirsner R. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. [Internet]. 2017 (citado 15 noviembre 2023);18:355–372. DOI: 10.1007/s40257-017-0251-7
Chen B, Li W, Qu B. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med (Lausanne) [Internet]. 14 febrero 2023 (citado 15 noviembre 2023);10:1134939. DOI: 10.3389/fmed.2023.1134939
Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG. Pyoderma Gangrenosum: Treatment Options. Drugs [Internet]. Septiembre 2023 (citado 15 noviembre 2023);83(14):1255-1267. DOI: 10.1007/s40265-023-01931-3
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Array